
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Gα 15 CRISPR/Cas9 KO Plasmid (h2) | sc-403266-KO-2 | 20 µg | $397.00 |
GNA15 encodes the human heterotrimeric G protein alpha subunit Gα15, a promiscuous Gq-family mediator that couples diverse G protein–coupled receptors to phospholipase Cβ activation. Upon receptor engagement, Gα15 promotes inositol trisphosphate and diacylglycerol signaling, intracellular Ca²⁺ mobilization, protein kinase C activity, and downstream transcriptional programs that shape secretion, chemotaxis, and inflammatory responses. This signaling axis intersects with MAPK and other second-messenger pathways, influencing cell activation states across immune and hematopoietic contexts. Altered GPCR–Gα15 coupling and dysregulated calcium-dependent signaling have been implicated in cancer- and inflammation-associated phenotypes, supporting its use in mechanistic studies of receptor rewiring and signal integration.
Gα 15 CRISPR/Cas9 KO Plasmid (h2) is a pool of plasmids designed for targeted disruption of the GNA15 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the GNA15 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the GNA15 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Gα 15 protein expression.
This CRISPR knockout system enables efficient generation of GNA15-deficient cell models for investigation of Gα 15 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.